K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation

por Virgili, Noemí, Mancera, Pilar, Wappenhans, Blanca, Sorrosal, Georgina, Biber, Knut, Pugliese, Marco, Espinosa-Parrilla, Juan F.
Publicado 2013

Correction: K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation

por Virgili, Noemí, Mancera, Pilar, Wappenhans, Blanca, Sorrosal, Georgina, Biber, Knut, Pugliese, Marco, Espinosa-Parrilla, Juan F.
Publicado 2013

Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice

por Mancera, Pilar, Wappenhans, Blanca, Cordobilla, Begoña, Virgili, Noemí, Pugliese, Marco, Rueda, Fèlix, Espinosa-Parrilla, Juan F., Domingo, Joan C.
Publicado 2017

Oral administration of the K(ATP )channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis

por Virgili, Noemí, Espinosa-Parrilla, Juan F, Mancera, Pilar, Pastén-Zamorano, Andrea, Gimeno-Bayon, Javier, Rodríguez, Manuel J, Mahy, Nicole, Pugliese, Marco
Publicado 2011